Lack of Association Between Serotonin Transporter Gene (SLC6A4) Promoter Methylation and Amygdala Response During Negative Emotion Processing in Individuals With Alcohol Dependence. (22nd April 2019)

• Record Type: Journal Article
• Authors: Muench, Christine; Luo, Audrey; Charlet, Katrin; Lee, Jisoo; Rosoff, Daniel B; Sun, Hui; Fede, Samantha J; Jung, Jeesun; Momenan, Reza; Lohoff, Falk W
• Is Part Of: Alcohol and alcoholism. Volume 54:Number 3(2019)
• Page Start: 209
• Page End: 215
• Publication Date: 2019-04-22
• Subjects: Alcoholism -- Periodicals; 616.861005
• DOI: 10.1093/alcalc/agz032
• Languages: English
• ISSNs: 0735-0414

Abstract

Abstract : There is no statistically significant association between methylation in the promoter region of the serotonin transporter gene ( SLC6A4 ) and amygdala activation during negative emotion processing in individuals with alcohol dependence or healthy controls. Abstract: Aims: Differences in DNA methylation of the serotonin transporter gene ( SLC6A4 ) have been shown to alter SLC6A4 expression and predict brain functions in healthy individuals. This study investigated the association between SLC6A4 promoter methylation and threat-related amygdala activation in individuals with alcohol dependence (AD). Methods: Methylation of the SLC6A4 promoter region was assessed using peripheral blood DNA from 45 individuals with AD and 45 healthy controls (HCs). All participants completed an emotional face matching task in a 3-T magnetic resonance imaging (MRI) scanner. Results: Results did not reveal any association between SLC6A4 promoter methylation variation and threat-related amygdala activation in HCs or individuals with AD. Furthermore, methylation in the promoter region of SLC6A4 did not significantly differ between the groups. Conclusions: Our results do not replicate a previous finding that increased methylation in the promoter region of SLC6A4 is associated with threat-related amygdala activation in healthy individuals and further show that there is no such association in individuals with AD. Given that the number of imaging epigenetics studies on SLC6A4 is very limited to date, these inconsistent results indicate that future research is needed to clarify its association with amygdala reactivity in both healthy and clinical populations.